Hwaseong-si, South Korea

Jin Young Kim

This inventor holds 1 USPTO granted patent. Top assignee: Hanmi Pharm. Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jin Young Kim. Retrieved from https://idiyas.com/inventor/jin-young-kim-bx1m13z7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jin Young Kim: Innovator in Immune-Stimulating Therapies

Introduction

Jin Young Kim is a prominent inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of immunology through his innovative research and development efforts. His work focuses on creating novel therapeutic solutions that enhance immune responses.

Latest Patents

Jin Young Kim holds a patent for a "Novel Conjugate of Immune-Stimulating IL-2 Analog and Preparation Method Thereof." This patent represents a breakthrough in the development of immune-stimulating therapies, showcasing his commitment to advancing medical science.

Career Highlights

Currently, Jin Young Kim is employed at Hanmi Pharmaceutical Co., Ltd., where he continues to push the boundaries of pharmaceutical innovation. His expertise in immunology has positioned him as a key player in the development of new therapeutic agents.

Collaborations

Throughout his career, Jin Young Kim has collaborated with notable colleagues, including Yong Ho Heo and Euh Lim Oh. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Jin Young Kim's contributions to the field of immunology through his patent and work at Hanmi Pharmaceutical Co., Ltd. highlight his role as an influential inventor. His ongoing efforts in developing immune-stimulating therapies are paving the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…